Andrew Ashe - Dec 2, 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
President, Chief Operating Officer
Signature
/s/ Andrew Ashe
Stock symbol
VERV
Transactions as of
Dec 2, 2021
Transactions value $
$128,420
Form type
4
Date filed
12/6/2021, 07:12 AM
Previous filing
Jun 21, 2021
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Purchase $128K +4K +2.4% $32.10 171K Dec 2, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $31.93 to $32.12 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

Remarks:

President, Chief Operating Officer